World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
73
Citations
18500
World Ranking
2147
National Ranking
82

Yasuo Morishima publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Yasuo Morishima sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 378 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Yasuo Morishima D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Yasuo Morishima sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 73 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Yasuo Morishima is affiliated with Aichi Medical University in Japan and has contributed extensively to the fields of medicine and immunology. Their research primarily focuses on hematopoietic stem cell transplantation and immune cell function, covering related areas such as T-cell and B-cell immunology, genetics, oncology, and pathology.

The main topics of Morishima's work include:

  • Hematopoietic Stem Cell Transplantation
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Mesenchymal stem cell research
  • Lymphoma Diagnosis and Treatment
  • Immunotherapy and Immune Responses
  • Cytomegalovirus and herpesvirus research

Morishima has published papers in several prominent journals. Some recent notable publications are:

  • Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation, 2020, Journal of Clinical Oncology
  • HLA-B Leader and Survivorship after HLA-Mismatched Unrelated Donor Transplantation, 2020, Blood
  • Capturing Differential Allele-Level Expression and Genotypes of All Classical HLA Loci and Haplotypes by a New Capture RNA-Seq Method, 2020, Frontiers in Immunology
  • Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor Program, 2021, Transplantation and Cellular Therapy
  • Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status, 2020, Bone Marrow Transplantation

The frequent publication venues for their research include:

  • Transplantation and Cellular Therapy
  • Blood
  • Bone Marrow Transplantation
  • Frontiers in Immunology
  • Cancers

Morishima often collaborates with several coauthors, reflecting an active engagement in multidisciplinary research efforts. Frequent coauthors include:

  • Satoko Morishima
  • Takahiro Fukuda
  • Makoto Onizuka
  • Yoshiko Atsuta
  • Naoyuki Uchida

Their work spans medicine and immunology and microbiology, further refining subfields such as hematology, genetics, oncology, and pathology and forensic medicine. Across these subfields, Morishima's publications provide insights into the interaction between immune cells and transplantation outcomes, as well as advancements in genetic profiling methods related to immune system function.

Best Publications

  • Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor

    Takehiko Sasazuki;Takeo Juji;Yasuo Morishima;Naoko Kinukawa

  • Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders Constitute a Distinct Clinicopathologic Group: A Study of 96 Patients

    Takashi Oyama;Kazuhito Yamamoto;Naoko Asano;Aya Oshiro

  • A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue.

    Tomoaki Akagi;Mutsuhito Motegi;Akiko Tamura;Ritsuro Suzuki

  • Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System.

    Yoshiko Atsuta;Ritsuro Suzuki;Ayami Yoshimi;Hisashi Gondo

  • De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients

    Motoko Yamaguchi;Masao Seto;Masataka Okamoto;Ryo Ichinohasama

  • Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study

    Katharina Fleischhauer;Bronwen E. Shaw;Bronwen E. Shaw;Theodore Gooley;Mari Malkki

  • TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas

    Keiichiro Honma;Shinobu Tsuzuki;Masao Nakagawa;Hiroyuki Tagawa

  • High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism.

    Takakazu Kawase;Yasuo Morishima;Keitaro Matsuo;Koichi Kashiwase

  • Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study

    Masakatsu Hishizawa;Junya Kanda;Atae Utsunomiya;Shuichi Taniguchi

  • Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia

    Yoshiko Atsuta;Ritsuro Suzuki;Tokiko Nagamura-Inoue;Shuichi Taniguchi

  • Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma

    Yasushi Yatabe;Ritsuro Suzuki;Kensei Tobinai;Yoshihiro Matsuno

  • Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype

    Ritsuro Suzuki;Yoshitoyo Kagami;Kengo Takeuchi;Masahiro Kami

  • CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.

    Ritsuro Suzuki;Kazuhito Yamamoto;Masao Seto;Yoshitoyo Kagami

  • Genome‐wide array‐based comparative genomic hybridization of natural killer cell lymphoma/leukemia: Different genomic alteration patterns of aggressive NK‐cell leukemia and extranodal Nk/T‐cell lymphoma, nasal type

    Yasuhiro Nakashima;Hiroyuki Tagawa;Ritsuro Suzuki;Sivasundaram Karnan

  • A Genetic Variant in the IL-17 Promoter Is Functionally Associated with Acute Graft-Versus-Host Disease after Unrelated Bone Marrow Transplantation

    J. Luis Espinoza;Akiyoshi Takami;Katsuya Nakata;Makoto Onizuka

  • KIR Ligands and Prediction of Relapse after Unrelated Donor Hematopoietic Cell Transplantation for Hematologic Malignancy

    Katharine C. Hsu;Ted Gooley;Mari Malkki;Clara Pinto-Agnello

  • Anaplastic large cell lymphoma : a distinct molecular pathologic entity : a reappraisal with special reference to p80(NPM/ALK) expression

    Shigeo Nakamura;Mami Shiota;Atsuko Nakagawa;Yasushi Yatabe

  • Identification of a Polymorphic Gene, BCL2A1, Encoding Two Novel Hematopoietic Lineage-specific Minor Histocompatibility Antigens

    Yoshiki Akatsuka;Tetsuya Nishida;Eisei Kondo;Mikinori Miyazaki

  • Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program.

    Seiji Kojima;Takaharu Matsuyama;Shunichi Kato;Hisato Kigasawa

  • Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.

    Katsuto Takenaka;Tetsuya Nishida;Yuki Asano-Mori;Kumi Oshima

  • Age-related Epstein-Barr virus (EBV)–associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients

    Naoko Asano;Naoko Asano;Kazuhito Yamamoto;Jun Ichi Tamaru;Takashi Oyama

  • Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes

    Soo Young Yang;Yasuo Morishima;Nancy H. Collins;Thomas Alton

Frequent Co-Authors

Masao Seto
Masao Seto Kurume University
Shigeo Nakamura
Shigeo Nakamura Nagoya University
Ritsuro Suzuki
Ritsuro Suzuki Shimane University
Keitaro Matsuo
Keitaro Matsuo Nagoya University
Nobuyuki Hamajima
Nobuyuki Hamajima Nagoya University
Toshitada Takahashi
Toshitada Takahashi Nagoya University
Yasushi Yatabe
Yasushi Yatabe Nagoya University
Kazuo Tajima
Kazuo Tajima Kagoshima University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your expertise through related online degrees can open doors to specialized healthcare roles. One such pathway is becoming a Psychiatric Mental Health Nurse Practitioner (PMHNP). To explore quality programs, consider the best psychiatric mental health nurse practitioner programs online, which offer strong clinical placement support.

Cost is often a deciding factor for many students. If budget constraints are a concern, the cheapest pmhnp certificate programs provide affordable paths to certification without sacrificing quality education.

When choosing a career trajectory, understanding potential earnings is crucial. Those holding a Doctor of Nursing Practice (DNP) degree can check the dnp salary by state to assess salary prospects depending on their geographic preferences.

For nurses aiming to broaden their scope, transitioning from Family Nurse Practitioner (FNP) to specialized roles is a viable option. Guidance on certification can be found in the resource on acute care nurse practitioner certification, which outlines the necessary steps to advance in acute care settings.

Best Scientists Citing Yasuo Morishima

Trending Scientists

Recently Published Articles